4th Circ. Rips 'Shaky At Best' Drug Price-Fixing Class Action

By Ryan Harroff · February 27, 2025, 4:45 PM EST

The Fourth Circuit backed the dismissal of a proposed class action accusing drug companies of conspiring to inflate the price of a drug for Huntington's disease, writing in the opinion that...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

MSP Recovery Claims, Series LLC v. Lundbeck LLC

Case Number

Court

Appellate - 4th Circuit

Nature of Suit

3470 Civil (Rico)

Date Filed

January 12, 2024

Recent Articles By Ryan

March 03, 2025
Justices Decline Data Breach Suit Against SC Medical Center
February 24, 2025
Justices Won't Review NJ Town Abortion Buffer Zone Law
February 11, 2025
CVS, Aetna Escape Testing Lab's $20.6M Unpaid Invoices Suit
February 10, 2025
UnitedHealthcare Fined $3.4M In NC Over Billing Shortfalls
January 28, 2025
North Carolina Drug Testing Lab Inks $850K False Billing Deal
January 15, 2025
Atrium Health Accused Of Giving Patient Data To Google
January 13, 2025
Duke Health Worker Agrees To Arbitrate Bias Suit, For Now
January 13, 2025
Feds Say NC Medical Biz Owner Overbilled For Nutrient Drinks
January 10, 2025
Ex-CEO's Sentencing In COVID Test Securities Fraud Delayed
January 03, 2025
Physician Assistant Can't Avoid Suspension For Hiding Probe